DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 4Dr. Reddy's Laboratories
02 4Taro Pharmaceutical Industries
03 3AAIPharma Services Corp.
04 2ANI Pharmaceuticals Inc
05 4Actavis Inc
06 4Ajanta Pharma Limited
07 4Alembic Pharmaceuticals Limited
08 4Amneal Pharmaceuticals
09 4Apotex Inc
10 4Aurobindo Pharma Limited
11 6Bayer AG
12 13Bristol Myers Squibb
13 4Chartwell Pharmaceuticals llc
14 1Fresenius Kabi USA
15 4Glenmark Pharmaceuticals
16 2H. Lundbeck AS
17 7Lannett Company, Inc.
18 4MSN Laboratories
19 4Novitium Pharma LLC
20 2PHARM ASSOC
21 3Pharmascience Inc.
22 4Prasco Laboratories
23 1Quad Pharma
24 4Rising Pharmaceuticals Inc
25 9Sandoz B2B
26 4TWi Pharmaceuticals
27 4Torrent Pharmaceuticals Limited
28 4Upsher-Smith Laboratories
29 4Zydus Lifesciences
01 4CONCENTRATE;ORAL
02 3ELIXIR;ORAL
03 1Fluphenazine 25Mg 1 Unit Parenteral Use
04 3INJ
05 3INJECTABLE;INJECTION
06 1Injectable; Injection
07 1SOLUTION FOR INJECTION
08 6TABLET
09 1TABLET, EXTENDED RELEASE;ORAL
10 96TABLET;ORAL
11 2Blank
01 32DISCN
02 3Originator
03 6Prescription
04 71RX
05 9Blank
01 1Dominans
02 3FLUPHENAZINE
03 1FLUPHENAZINE HCL
04 93FLUPHENAZINE HYDROCHLORIDE
05 3Modecate
06 1Moditen Depot
07 6PERMITIL
08 1PMS FLUPHENAZINE TAB 1MG
09 1PMS FLUPHENAZINE TAB 2MG
10 1PMS FLUPHENAZINE TAB 5MG
11 7PROLIXIN
12 1PROLIXIN ENANTHATE
13 1Siqualone decanoat
14 1Strong Dominans
01 6Canada
02 3Italy
03 3South Africa
04 1Sweden
05 108USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : FLUPHENAZINE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 1MG
Packaging :
Approval Date : 2021-01-07
Application Number : 214534
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : FLUPHENAZINE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG
Packaging :
Approval Date : 2021-01-07
Application Number : 214534
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : FLUPHENAZINE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2021-01-07
Application Number : 214534
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : FLUPHENAZINE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2021-01-07
Application Number : 214534
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FLUPHENAZINE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 1MG
Packaging :
Approval Date : 2022-04-14
Application Number : 215674
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FLUPHENAZINE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG
Packaging :
Approval Date : 2022-04-14
Application Number : 215674
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FLUPHENAZINE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2022-04-14
Application Number : 215674
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FLUPHENAZINE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2022-04-14
Application Number : 215674
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PERMITIL
Dosage Form : TABLET;ORAL
Dosage Strength : 0.25MG
Packaging :
Approval Date : 1982-01-01
Application Number : 12034
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PERMITIL
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG
Packaging :
Approval Date : 1982-01-01
Application Number : 12034
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PERMITIL
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 1982-01-01
Application Number : 12034
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PERMITIL
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 1982-01-01
Application Number : 12034
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PERMITIL
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 1MG
Packaging :
Approval Date : 1982-01-01
Application Number : 12419
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PERMITIL
Dosage Form : CONCENTRATE;ORAL
Dosage Strength : 5MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 16008
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PROLIXIN
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 11751
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PROLIXIN
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 11751
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PROLIXIN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 11751
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PROLIXIN
Dosage Form : TABLET;ORAL
Dosage Strength : 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 11751
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PROLIXIN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 2.5MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 11751
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PROLIXIN
Dosage Form : ELIXIR;ORAL
Dosage Strength : 2.5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 12145
Regulatory Info : DISCN
Registration Country : USA
LOOKING FOR A SUPPLIER?
